
Curriculum Vitae
AREAS OF EXPERTISE
-
CLINICAL ONCOLOGY WHICH COVERS ALL ASPECTS OF NON-SURGICAL TREATMENT MODALITIES FOR CANCER PATIENTS IN PARTICULAR WITH RADIOTHERAPY, CYTOTOXICS, HORMONES AND BIOLOGICS. TUMOUR SITE SPECIALIZATION INCLUDES BREAST,LUNG, BRAIN, LYMPHOPROLIFERATIVE TISSUE, PAEDIATRICS AND SKIN.
ACADEMIC QUALIFICATION
-
FRCR(UK)(2000), (Radiotheraphy & Oncology)Royal College of Radiologist, London
-
MBBS(CARDIFF)(1992), (Medicine and Surgery)University of Wales College of Medicine, Cardiff
ADMINISTRATIVE DUTIES
- AJK Penulisan Kurikulum Nasional Sarjana Perubatan Klinikal bagi bidang Onkologi Klinikal01 Jan 2016 - present (National)
- Ahli Jawatankuasa PPGP01 Oct 2013 - present (Faculty)
- Postgraduate Curriculum Working Group23 Sep 2014 - present (Faculty)
- Clinical Oncology Specialty Committee member01 Jan 2021 - 31 Dec 2021 (National)
- National curriculum writing group member01 Jan 2021 - 31 Dec 2021 (National)
- National Project Coordinator30 Jan 2018 - 31 Dec 2021 (International)
- JKKF Committee member06 Apr 2017 - 05 Apr 2020 (University Malaya)
- HRPP Committee member02 May 2017 - 01 May 2019 (Faculty)
- Programme Coordinator02 Sep 2016 - 01 Sep 2017 (University Malaya)
- Quality Manager04 Jul 2016 - 03 Jul 2017 (University Malaya)
- Programme Coordinator01 Sep 2014 - 01 Sep 2016 (Faculty)
- Quality Manager01 Jul 2014 - 01 Jul 2016 (Faculty)
- Head01 Sep 2012 - 31 Aug 2013 (Universiti Malaya)
- Head Coordinator01 Oct 2002 - 31 Aug 2013 (Faculty)
- Head of Department01 Aug 2000 - 31 Aug 2013 (Faculty)
- National Project Coordinator for IAEA project RAS604001 Jan 2005 - 31 Dec 2009 (National)
MEMBERSHIPS
- FARO, ELECTED COUNCIL MEMBERSince 2014 (International)
- SEAROG, EXCO MEMBERSince 2014 (International)
- NPC SOCIETY OF MALAYSIA, LIFE MEMBERSHIPSince 2011 (National)
- MALAYSIAN ONCOLOGICAL SOCIETY, COMMITTEESince 2001 (National)
- FARO, COUNCIL MEMBER2019 to 2019 (International)
- SEAROG, ADVISOR2019 to 2019 (International)
AWARD AND STEWARDSHIP
- EXCELLENCE SERVICE AWARDUniversity of Malaya, 2020 (University)
- Certifcate of AppreciationFARO, 2019 (International)
- Certificate of appreciationFaculty of Medicine,UM, 2019 (University)
- Appreciation letterFARO 2018 organising committee, 2018 (International)
- Live surgery IORT workshopCollege of Surgeons and Academy of Medicine Malaysia, 2017 (National)
- Certificate of appreciationUMMC, 2017 (National)
- Letter of appreciationUniversiti Malaya, 2016 (University)
- Certificate of appreciationMASPHO, 2016 (National)
- Certificate of AppreciationMalaysian Psychiatric Association, 2016 (National)
- CERTIFICATE OF EXCELLENT SERVICEUniversity of Malaya, 2014 (University)
- AppreciationUMMC, 2014 (Community)
- KHIDMAT SETIA 20 AWARD, 2013
- EXCELLENCE SERVICE AWARDUniversity of Malaya, 2012 (University)
- AppreciationIAEA, 2012 (National)
- Anugerah Khidmat CemerlangUniversiti Malaya, 2012 (University)
- Eskpo Penyelidikan, Rekacipta dan Inovasi UM 2009Universiti Malaya, 2009 (University)
- Anugerah Khidmat CemerlangUniversiti Malaya, 2009 (University)
- EXCELLENCE SERVICE AWARDUniversity of Malaya, 2009 (University)
- CERTIFICATE OF EXCELLENT SERVICEUniversity of Malaya, 2007 (University)
- AppreciationDept of Biomedical Imaging, UMMC, 2007 (University)
- AppreciationNational cancer registry, 2007 (National)
- EXCELLENCE SERVICE AWARDUniversity of Malaya, 2006 (University)
- Anugerah Khidmat CemerlangUniversiti Malaya, 2006 (University)
- Bronze medal for the category of Fundamental Research: Oxidative stress biomarkers in breast cancer. Eskpo Penyelidikan, Rekacipta dan Inovasi 2006, 18-20 JulaiUniversiti Malaya, 2006 (University)
- Gold medal for the category of Invention & Innovation sempena Eskpo Penyelidikan, Rekacipta dan Inovasi 2005, 14-17 Jun. Oral Cancer Database Software- Real and Virtual Tumor Bank System (OCDS/RVTBS)- An Aid for Multicenter Studies.Universiti Malaya, 2005 (University)
- CERTIFICATE OF EXCELLENT SERVICEUniversity of Malaya, 2005 (University)
- Appreciationministry of health, 2004 (National)
- AppreciationMITC, UMMC, 2004 (University)
- AppreciationMOH, 2004 (National)
- EXCELLENCE SERVICE AWARDUniversity of Malaya, 2003 (University)
- AppreciationNational cancer registry, 2003 (National)
- Anugerah Khidmat CemerlangUniversiti Malaya, 2003 (University)
- Anugerah Khidmat CemerlangUniversiti Malaya, 2002 (University)
- Anugerah Khidmat CemerlangUniversiti Malaya, 2001 (University)
PUBLICATIONS
Article in Journal
WoS
-
See, M. H., Ung, N. M., Wong, J. H. D., Zaili, Z., Malik, R. A., Bustam, A. Z., . . . Taib, N. A. M. (2021). Evaluation of skin dose and skin toxicity in patients undergoing intraoperative radiotherapy for early breast cancer. Journal of Applied Clinical Medical Physics, 22(8), 139-147. doi: 10.1002/acm2.13338
-
Kong, Y. C., Bhoo-Pathy, N., ORorke, M., Subramaniam, S., Bhoo-Pathy, N. T., See, M. H., . . . Yip, C. H. (2020). The association between methods of biopsy and survival following breast cancer A hospital registry based cohort study. Medicine, 99(6), 7. doi: 10.1097/md.0000000000019093
-
Ghani, W. M. N., Ramanathan, A., Prime, S. S., Yang, Y. H., Razak, I. A., Rahman, Z. A. A., . . . Zain, R. B. Survival of Oral Cancer Patients in Different Ethnicities. Cancer Investigation, 13. doi:10.1080/07357907.2019.1635614
-
Iwata, H., Masuda, N., Kim, S. B., Inoue, K., Rai, Y., Fujita, T., . . . Chan, A. (2019). Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer. Future Oncology, 15(21), 2489-2501. doi:10.2217/fon-2019-0143
Others
-
Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early-stage HER2-positive breast cancer
-
Survival of oral cancer patients in different ethnicity
-
MARNIZA SAAD, Flora Li Tze Chong, Anita Zarina Bustam, Gwo Fuang Ho, Rozita Abdul Malik, Wan Zamaniah Wan Ishak, Vincent Chee Ee Phua, Mastura Md Yusof, Ning Yi Yap, Adlinda Alip. The efficacy and tolerability of scalp cooling in preventing chemotherapy induced alopecia in patients with breast cancer receiving anthracycline and taxane based chemotherapy in an Asian setting. Ind Journal of Cancer, 2018;157-161.
-
Syadwa Abdul Shukor, Anita Zarina Bustam, Palliative radiotherapy for advanced Cancer: Are we giving it to the right patient at the right time?Med J Malaysia Vol 73 No 4 August 2018
-
Miguel Martin, MD et al. Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Oncology Nov 13, 2017
-
Moradi, F., Ung, N.M., Khandaker, M.U., Mahdiraji, G.A., SAAD, M., Malik, R.A., Bustam, A.Z., Zaili, Z. and Bradley, D.A.,(2017). Monte Carlo skin dose simulation in intraoperative radiotherapy of breast cancer using spherical applicators. Physics in medicine and biology. 62, 6550-66.
-
Rosenblatt, E.,Prajogi, G. B., Barton, M., Fidarova, E.,Eriksen, J. G., Haffty, B., Millar, B. A.,Bustam,A., Zubizarreta, E., & Abdel-Wahab,M. (2017). Need for Competency-Based Radiation Oncology Education in Developing Countries. Creative Education, 8, 66-80.
-
The challenges of treating childhood medulloblastoma in a country with limited resources: 20 years experience at a single tertiary centre in Malaysia. Journal of Global Oncology, 2016
-
Chandramathi S, Suresh K, Anita ZB, Rokiah P, Kuppusamy UR. Urinary Advanced Oxidation Protein Product (AOPP): A Potential Oxidation Damage Marker for Cancer . West Indian Medical Journal, In press.
-
Vincent Chee Ee Phua, Wei Quan Wong, Pei Lin Tan, Anita Zarina Bustam, MARNIZA SAAD, Adlinda Alip, Wan Zamaniah Wan Ishak. Capecitabine Pattern of Usage, Rate of Febrile Neutropaenia and Treatment Related Death in Asian Cancer Patients in Clinical Practice
-
Yahaya NA1, Subramanian P, Bustam AZ, Taib NA.2015.Symptom Experiences and Coping Strategies among Multi- ethnic Solid Tumor Patients Undergoing Chemotherapy in Malaysia.Asian Pac J Cancer Prev 16(2):723-30.
-
Nor Zuraida Zainal, Norley Shuib, Anita Zarina Bustam, Zuraida Ahmad Sabki, Ng Chong Guan. 2013. Reliability and Validity of the Malay Version of the Breast-Impact of Treatment Scale (MVBITS) in Breast Cancer Women undergoing Chemotherapy. Asian Pacific J Cancer Prev, 14 (1), 463-468
-
Zain RB, Athirajan V, Ghani WM, Razak IA, Raja Latifah RJ, Ismail SM, Sallam AA, Bustam AZ, Rahman ZA, Hussien A, Talib N, Cheong SC, Jallaludin A.2013 An oral cancer biobank initiative: a platform for multidisciplinary research in a developing country. Cell Tissue Bank. 14(1):45-52
-
Chee Ee Phua, Anita Zarina Bustam, Mastura Md Yusof, MARNIZA SAAD, Cheng-Har Yip, Nor Aishah Taib and Char Hong Ng. 2012 Risk of treatment related death (TRD) with adjuvant chemotherapy for breast cancer: A study in University Malaya Medical Centre (UMMC). Journal of Cancer Therepeutics & Research 1: 13
-
Phua Chee Ee, Anita Zarina Bustam,Mastura Md Yusof, MARNIZA SAAD,Yip Cheng-Har, Nor Aishah Taib, Ng Char Hong, Teh Yew Ching 2012. Risk of Treatment Related Death and Febrile Neutropaenia with Taxane-Based Adjuvant Chemotherapy for Breast Cancer in a Middle Income Country Outside a Clinical Trial Setting. Asia Pacific Journal of Cancer Prevention; 13(9), 4623-4626.
-
Chandramathi S,Suresh K,Anita ZB,Kuppusamy UR (2011). Infection of Blastocystis hominis and microsporidia: are they opportunistic? Trans. R. Soc. Trop. Med. Hyg.
-
Chong HY, Taib NA, Rampal S, Saad M, Bustam AZ, Yip CH. Treatment options for locally advanced breast cancer experience in an Asian Tertiery Hospital Asian Pac J of Cancer Prev 2010;11(4):913-7.
-
Choong LP, Taib NA, Rampal S, SAAD M, Bustam AZ, Yip CH. High tumour stage and margin clearance are still important prognostic factors for postmastectomy locoregional recurrence in Malaysia. Asian Pac J Cancer Prev 2010;11(4):1409-16.
-
Hoong-Yin Chong, Nur Aishah Taib, Sanjay Rampal, Marniza Saad, Anita Zarina Bustam, Cheng-Har Yip. Treatment options for locally advanced breast cancer - experience in an Asian tertiary hospital. APJCP, 11:2010;1-5.
-
Lau Peng Choong, Nur Aishah Mohd Taib, Sanjay Rampal, Marniza Saad, Anita Zarina Bustam, Yip Cheng Har; High Tumour Stage and Margin Clearance are still important prognostic factors for post-mastectomy locoregional recurrence in Malaysia; Asian Pacific Journal for Cancer Prevention,11,1409-1416 Dec 2010
-
Phua CE, Bustam AZ, Yip CH, Taib NA. 2010. Prognostic factors for elderly breast cancer patients in University Malaya Medical Centre, Malaysia. Asian Pac J Cancer Prev. 11(5):1205-11.
-
Prognostic Factors for Elderly Breast Cancer Patients in University Malaya Medical Centre, Malaysia CE Phua1*, AZ Bustam2, Cheng-Har Yip3, Nor Aishah Taib3 2010 Asian Pacific J Cancer Prev, 11, 1205-1211
-
Seriramalu R, Pang W, Jayapalan JJ, Mohamed E, Abdul- Rahman PS, Bustam AZ, Khoo ASB, Hashim OH;Application of champedak mannose-binding lectin in the glycoproteomic profiling of serum samples unmasked reduced expression of alpha-2 macroglobulin and complement factor B in patients with nasopharyngeal carcinoma. Electrophoresis 31:14, 2388-2395 Jul 2010
-
Shingo Kato, Tatsuya Ohno, Kullathorn Thephamongkol, Yaowalak Chansilpa, Yang Yuxing, C.R.Beena Devi, Anita Z. Bustam, Miriam J.C. Calaguas, Rey H. De Los Reyes, Chul-Koo Cho, To Anh Dung, Nana Supriana, Hideyuki Mizuno, Takashi Nakano, Hirohiko Tsujii. Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia. Int J Radiation Oncology Biol Phys Vol 77 No 3 pg 751-757, 2010
-
S. Chandramathi, K. Suresh, Z. B. Anita, U. R. Kuppusamy. Attenuation of serum H2O2 and FRAP levels in colorectal cancer patients with intestinal parasitic infection. Mal J Med Sci (2009) 16(2), 15-20
-
S.Chandramathi,K.Suresh,Z.B.Anita,U.R.Kuppusamy. Elevated levels of urinary hydrogen peroxide, advanced oxidative protein product (AOPP) and malonaldehyde in humans infected with intestinal parasites.Cambridge University Press. Parasitology (2009) 136, 359-363
-
Emida Mohamed1 ,Puteri Shafinaz Abdul-Rahman1, Saeid Reza Doustjalali1,Yeng Chen1, Boon-Kiong Lim2, Siti Zawiah Omar2, Anita Zarina Bustam3, Vivek Ajit Singh4, Nur Aishah Mohd-Taib5, Cheng-Har Yip5, Onn Haji Hashim1.1Dept of Molecular Medicine, 2Dept. Of Obstetrics and Gynaecology, 3Clinical Oncology Unit, 4Dept. Of Orthopaedic Surgery, 5Dept. Of Surgery, Faculty of Medicine, University of Malaya. Lectin- based electrophoretic analysis of the expression of the 35 kDa inter- - trypsin inhibitor heavy chain H4 fragment in sera of patients with five different malignancies. 2008, 29, 2645-2650
-
S.Chandramathi,K.Suresh,Z.B. Anita,U.R.Kuppusamy. Comparative assessment of urinary oxidative indices in breast and colorectal cancer patients. J cancer Res Clin Oncol (2009) 135:319-325 Published online 29 Aug 2008
-
Nor ZAINAL, Koh HUI, Ting HANG and Anita BUSTAM. Department of Psychological Medicine and Clinical oncology Unit, Faculty of Medicine, Universiti Malaya. Prevalence of distress in cancer patients undergoing chemotherapy. Asia Pacific Journal of Clinical Oncology 2007; 3: 219-223 (Full paper)
-
Kei Siong Khoo, Syed Hasan Manzoor Zaidi, Vichien Srimuninnimit, Santai Song, Reena Nair, Corazon A. Ngelangel, Anita Bustam, William H.H Reece, Manfred Lehnert.Gemcitabine and split dose paclitaxel or docetaxel in metastatic breast cancer: a randomized phase II study. European Journal of Cancer 42 (2006) 1797-1806 (Full paper)
-
Saeid R. Doustjali, Rohana Yusof, Gopala K. Govindasamy, Anita Z. Bustam, Bhanumathy Pillay, and Onn H. Hashim. Patients with nasopharyngeal carcinoma demonstrate enhanced serum and tissue ceruloplasmin expression. The Journal of Medical Investigation Vol. 53 No. 1,2, February, 2006 (Full paper)
-
R.B. Zain, Raja Latifah RJ, Razak IA, Ismail SM, Atiya SA, Hashim BY, Jallaludin A, Bustam AZ, Rahman ZAA, Krishnan G, Kipli NP, Samsudin AR, Nasir WM, Mahadzir WMW, Abraham MT, Norma J, Tay KK, Yuen KM, Cheong SC and Other MOCRI team members. Oral cancer and Precancer in Malaysia The Database and Tissue Resource Bank. Oral Oncology, MacMillan India; 2005. Vol 10: 3-12 (Full paper)
-
Si Lay Khaing, V Sivaratnam, Siti Zawiah Omar, Anita Zarina Bustam, Mun Kein Seong. Case Report: Small cell carcinoma of uterine cervix in a teen-aged girl a rare occurrence. Malaysian Journal of Obstetrics & Gynaecology 2005: Vol. 8 No. 9: 62-67 (Full paper)
Article in Proceeding
- Pawanchek M, Ung N-M*, Bustam A* and Ng K-H. Department of Biomedical Imaging, University of Malaya, *Clinical Oncology Unit, University of Malaya. In-vivo skin dose assessment for breast cancer during radiotherapy treatment using gafchromic film (EBT) detector. Proceedings 29th Annual General Meeting & Scientific Meeting of the College of Radiology Malaysia 3-4 June 2006. (Abstract)
- 5.R.B. Zain, R.J. Raja Latifah, I.A. Razak, S.M. Ismail, A.R. Samsuddin, S.A. Atiya, B.Y. Hashim, A. Jallaludin, W.M. Nasir, S.C. Cheong, A.Z.Bustam, W.M.W. Mahadzir, M.T.Abraham, Z.A.A. Rahman, G. Krishnan, N.P. Kipli, J. Norma, K.K. Tay, K.M. Yuen and other MOCRI Team Members. University of Malaya, Universiti Sains Malaysia, Ministry of Health Malaysia, Cancer Research Initiatives Foundation, Malaysia. Oral cancer and precancer research in Malaysia-the database and tissue resource bank. Proceedings of the 10th International Congress on Oral cancer, 19-24th April 2005, Island of Crete, Greece. Oral Oncology Supplement; April 2005; Vol 1 No 1; pp 123 (Abstract)
- K.-S. Khoo, M. Zaidi, V. Srimuninnimit, Z. F. Jiang, P. Prem Kumar, A. Bustam, A. H. Villalon, M. Lehnert; National Cancer Centre, Singapore;Baquai Institute of Oncology, Karachi, Pakistan; Siriraj Hospital, Mahidol University, Bangkok, Thailand; 307 Hospital, Academy of Military Medical Sciences, Beijing, China; MNJ Institute of Oncology & Regional Cancer Centre, Hyderabad, India; University Malaya Medical Centre, Kuala Lumpur, Malaysia; Manila Doctors Hospital, Manila, Philippines; Eli Lilly Asian Operations Ltd, Hong Kong, China.Randomized phase II trial of three gemcitabine (GEM)-taxane combinations in metastatic breast cancer (MBC). Vol. 23, 2004 American Society of Clinical Oncology Meeting Proceedings- (Abstract)
- Abdul Wahid, A Bustam, F Hayat P Rassiah and U Prasad.Re-treatment of 14 patients with recurrent nasopharyngeal carcinoma using CT simulation and conformal therapy. Radiotherapy and Oncology, Vol. 58 (Supplement1) pg.S97, 6th International Congress of Radiation Oncology Melbourne, Aus, Jan/Feb 2001- (Abstract)
RESEARCH INTEREST
- Clinical trials any solid tumour in particular breast cancer.
RESEARCH PROJECT
National
- 2012 - 2017, Quintiles Janseen CilaqABI-PRO- 3002 A phase 3, randamized, double-blind,placebo-controlled study of abiraterone acetate)JNJ-212082) plus prednisone in asymtomic ormildly symptomatic patients with metastaticcastration-resistant prostate cancer ( Consultant)
- 2011 - 2016, High Impact Research (HIR)Biobanking of Oral Cancers: An Assessment of Survival, Clinicopathological Parameters, Management Strategies Nutrition and Genetic Susceptibility of Patients ( Consultant)
- 2007 - 2015, ScienceFundDevelopment of Risk Models and Management Strategies for Oral Cancer ( Consultant)
- 2004 - 2015, IRPAOral cancer and precancer in Malaysia-risk factors, prognostic markers, genetic expression and impact on quality of life. ( Consultant)
- 2013 - 2015, RocheJACOB study:A Double-Blind, Placebo-Controlled, Randomized, Multicenter Phase III Study Evaluating The Efficacy and Safety of Pertuzumab in Combination with Trastuzumab and Chemotherapy in Patient with HER-2 Positive Metastatic Gastroesophageal Junction and Cancer ( Principal Investigator(PI))
- 2013 - 2015, NONEPhase II randomized study of docetaxel with or without low-dose, short course sunitinib in the treatment of advanced solid tumors. ( Consultant)
- 2013 - 2015, NONEProspective study of UDP-gluconoryltransferase (UGT) 2B17 genotype as a predictive marker of exemestane pharmacokinetics and pharmacodynamics in Asian women with hormone receptor-positive advanced breast cancer ( Consultant)
- 2011 - 2013, High Impact Research (HIR)Lapatinib study Phase II open-labelstudy of preoperativeweeklypac55 litaxel and carboplatinwithlapatinib (Tykerb ) in patientswith ErB2-positive stage I-III Breastc ncer ( Consultant)
- 2008 - 2012, WyethAn international multi-centre phase III randomised controlled trial of first line treatment of advanced renal cell carcinoma, comparing bevacizumab + interferon-alpha versus bevacizumab + torisel. ( Consultant)
- 2008 - 2012, Geran Penyelidikan Universiti Malaya (UMRG)Induction and concurrent chemoradiation with cetuximab for treatment of locally advanced Nasopharyngeal Carcinoma ( Consultant)
- 2010 - 2011, Postgraduate Research Grant(PPP)The Establishment of In-vitro Standard Dose Calibration Curve with High Energy X-ray and Measurement of The Equivalent Dose In Cancer Patients Treated with Radiotherapy Using Biological Dosimetry Technique ( Principal Investigator(PI))
- 2007 - 2010, GenentechA phase 3 multicentre, randomised, placebo- controlled trial evaluating the efficacy and safety of bevacizumab in combination with chemotherapy regimens in subjects with previously treated metastatic breast cancer. ( Consultant)
- 2008 - 2010, Short Term Research Fund (Vote F)(PJP)A prospective controlled study on the role of Scalp Hypothermia to prevent chemotherapy-induced Alopecia in patients with breast cancer receiving anthRacycline and taxanE-based chemotherapy. (SHARE Study) ( Consultant)
- 2008 - 2010, Geran Penyelidikan Universiti Malaya (UMRG)A Prospective controlled study on the role of Scalp Hypothermia to prevent chemotherapy-induced Alopecia in patients with breast cancer receiving anthRacycline and taxanE-based chemotherapy (SHARE Study) ( Consultant)
- 2007 - 2008, MOHA multi-institutional study on the clinical outcome of patients with nasopharyngeal carcinoma (NPC) and the establishment of a Malaysian NPC tissue bank. ( Consultant)
International
- 2021 - 2036, Private FundingA Randomized, Open-label Phase 3 Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared with Carboplatin-Pemetrexed, in Patients with EGFR Exon 20ins Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (PAPILLON) ( Consultant)
- 2020 - 2035, Private FundingEPIK-B3: A Phase III, multicenter, randomized, double-blind, placebo-controlled study to assess safety and efficacy of alpelisib (BYL719) in combination with nab-paclitaxel in patients with advanced triple negative breast cancer with either phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) mutation or phosphatase and tensin homolog protein (PTEN) loss without PIK3CA mutation ( Consultant)
- 2010 - 2026, NCC SingaporeASCOLT Aspirin in treating patients with Dukes stage C colon or rectal cancer, or high risk Dukes stage B colon cancer that has been completely removed by surgery. ( Consultant)
- 2018 - 2023, International FundingTROIKA study. Neoadj and adjuvant trastuzumab vs biosimilar in HER 2 positive EBC ( Principal Investigator(PI))
- 2010 - 2020, AmgenD- CARE A Randomised Double- Blind, Placebo- Controlled, Multi-Center Phase 3 Study of Denosumab as Adjuvant Treatment for Women with Early-Stage Breast Cancer at High Risk of Recurrence ( Principal Investigator(PI))
- 2016 - 2019, MSDMK3475-355 A Randomized, Double-Blind Phase III Study of Pembrolizumab (MK-3475) plus Chemotherapy vs Placebo plus Chemotherapy for Previously Untreated Inoperable Locally Recurrent or Metastatic Triple Negative Breast Cancer - (KEYNOTE-355) ( Principal Investigator(PI))
- 2015 - 2018, MSDA randomised open label phase 3 study of single agent pembrolizumab vs single agent chemo per physician's choice for metastatic triple negative breast cancer-[KEYNOTE-119 study] ( Principal Investigator(PI))
- 2010 - 2016, PfizerHKI 3004 Adjuvant breast cancer study in HER2 positive patients using neratinib. ( Principal Investigator(PI))
- 2010 - 2016, PfizerPhase 3 open label first line treatment for HER2 positive breast cancer comparing Paclitaxel plus herceptin vs Paclitaxel plus Neratinib. ( Consultant)
- 2014 - 2016, Samsung BioepisA Phase III Randomised, Double-Blind,Parallel Group, Multicentre Study to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity between SB3 (proposed trastuzumab biosimilar) and Herceptin in Women with Newly Diagnosed HER2 Positive Early or Locally Advanced Breast Cancer in Neoadjuvant Setting ( Consultant)
- 2010 - 2015, PfizerAGILE Axitinib in metastatic renal cell carcinoma patients. ( Consultant)
- 2014 - 2015, NUSA Prospective Cohort Study of Patients with Malignant Cord Compression ( Consultant)
- 2008 - 2014, GenentechBEATRICE ( Principal Investigator(PI))
- 2008 - 2012, WyethPhase 3b, randomised, open-label study of Bevacizumab + Temsirolimus vs Bevacizumab + Interferon-alfa as first-line treatment in subjects with advanced renal cell carcinoma. ( Consultant)
- 2009 - 2012, Boehringer-IngelheimLUME-Lung 2 An international, multi-centre phase III randomised controlled trial for second line treatment of recurrent, advanced non-small cell lung cancer, comparing pemetrexed + placebo versus pemetrexed + BIBF1120 (a multi-targeted tyrosine kinase inhibitor). ( Principal Investigator(PI))
- 2010 - 2012, AmgenASPECCT Panitumumab vs cetuximab for the third line treatment of advanced colorectal cancer. ( Consultant)
- 2006 - 2011, RocheSATURN/TITAN- A Multicentre, double blind randomized phase 3 study to evaluate the efficacy of Tarceva or placebo following 4 cycles of platinum-based chemotherapy in patients with histologically documented or advanced or recurrent or metastatic NSCLC who have not experienced disease progression or unacceptable toxicity during chemotherapy ( Principal Investigator(PI))
- 2008 - 2011, RocheA Phase 2 Biomarker identification Trial for Erlotinib in patients with Advanced Pancreatic carcinoma (MARK study) ( Principal Investigator(PI))
- 2008 - 2011, PfizerA multinational, randomised, open-label, phase 3 study of sunitinib malate vs sorafenib in patients with advanced hepatocellular carcinoma. ( Consultant)
- 2009 - 2011, Pfizer2009AG-013736 (Axitinib) as Second Line Therapy for Asian Patients with Metastatic Renal Cell Cancer ( Consultant)
- 2003 - 2008, FNCA, JapanConcurrent weekly Cisplatin and radiotherapy for advanced cervical cancer. ( Consultant)
- 2004 - 2008, GSKPhase II, open label study of SB-715992 in subjects with advanced or metastatic breast cancer. ( Consultant)
- 2005 - 2008, BMSA Phase III trial of novel Epothilone BMS-247550 plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with or resistant to an anthracycline and who are taxane resistant. ( Principal Investigator(PI))
- 2007 - 2008, GSKA Phase II, Open-label, Randomised, Multicenter Trial of GW786034 (Pazopanib) in combination with Lapatinib (GW 572016) compared to Lapatinib alone as first line therapy in subjects with advanced or metastatic breast cancer with erb-B2 FISH positive tumours. ( Consultant)
- 2001 - 2003, Eli LillyRandomised Phase 2 trial of Gemcitabine combined with a Taxane for metastatic breast cancer. ( Principal Investigator(PI))
CONSULTANCY PROJECT
- Malaysia Neratinib Expert Meeting, Specialised Therapeutics Asia., Consultant06 Nov 2021 - 06 Nov 2021 (National)
- Breast Cancer Expert Input Forum, MSD, Consultant23 Oct 2021 - 23 Oct 2021 (National)
- Collaborations of Radiation Oncology in Asia, JASTRO01 Dec 2016 - 01 Dec 2016 (International)
- Measurement of Bladder Volume Variations Using Portable Ultrasound Equipment: Introduction of Drinking Protocol, BIIJ01 May 2013 - 01 May 2013 (International)
- Eribulin in Breast Cancer Treatment, Eisai Malaysia Sdn Bhd01 Apr 2013 - 01 Apr 2013 (National)
- The Treatment Outcome of Radical Radiotherapy in Laryngeal Cancer, BIIJ01 Feb 2013 - 01 Feb 2013 (International)
- Penilaian Ubat-Ubatan Kemoterapi, UMMC01 Sep 2012 - 01 Sep 2012 (National)
- Radiation Oncology Training in Malaysia, IAEA01 Sep 2012 - 01 Sep 2012 (International)
- Erlotinib in First Line Egfr Mutation Positive Nsclc, Roche01 Aug 2012 - 01 Aug 2012 (National)
- Head of Panel of Judges for Oral Presentations At Ascomos 2012, Malaysian Oncological Society01 Apr 2012 - 01 Apr 2012 (National)
- Association of Creatinine Clearance With Neutropenia in Breast Cancer Patients Undergoing Chemotherapy With Fluorouracil, Doxorubicin, and Cyclophosphamide (Fac), MJM01 Feb 2012 - 01 Feb 2012 (National)
- Asia Pacific Cancer Conference 2011, Malaysian Oncological Society01 May 2008 - 01 May 2011 (International)
- Radioimmunotherapy-Based Treatment of Cancer, BIIJ01 Apr 2011 - 01 Apr 2011 (National)
- Induction Chemotherapy With Paclitaxel, Ifosfamide, and Cisplatin Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced Head and Neck Cancer, BIIJ01 Feb 2009 - 01 Feb 2009 (National)
- International Atomic Energy Agency (Iaea) Project Rca Ras 6040 Improvement in Quality of Radiotherapy for Frequent Cancers in The Region ., International Atomic Energy Agency (IAEA)01 Jan 2005 - 01 Jan 2009 (International)
- Medulloblastoma: Cranial Spinal Junctional Techniques., BIIJ01 Jan 2008 - 01 Jan 2008 (National)
- Poster Presentations Mos 2008, Malaysian Oncological Society01 Jan 2008 - 01 Jan 2008 (National)
- National Cancer Registry, Ministry of Health01 Jan 2003 - 01 Jan 2007 (National)
- Bachelor in Medical Sciences (Diagnostic Imaging)(UKM) Bachelor in Medical Sciences (Radiotherapy)(UKM) Phd(Diagnostic Imaging)(UKM) Phd(Radiotherapy)(UKM), UKM01 Jan 2003 - 01 Jan 2003 (National)
- Annual Scientific Meetings, Malaysian Oncological Society01 Jan 2001 - 01 Jan 2003 (National)
- 37th Malaysia-Singapore Congress of Medicine, Academy of Medicine01 Jan 2003 - 01 Jan 2003 (National)
- Bachelor in Medical Sciences (Diagnostic Imaging)(UKM) Bachelor in Medical Sciences (Radiotherapy)(UKM) Phd(Diagnostic Imaging)(UKM) Phd(Radiotherapy)(UKM), UKM01 Jan 2003 - 01 Jan 2003 (National)
- Mos Annual Scientific Meeting, Malaysian Oncological Society01 Jan 2001 - 01 Jan 2001 (National)
PAPER PRESENTED
INVITED SPEAKER
- Report of FARO Education and training committee, FARO Council Meeting, FARO (International) (18 Dec 2021 - 18 Dec 2021)
- TNBC in Malaysia. Keynote-355 study data & updates , Breast cancer expert input forum, MSD (National) (23 Oct 2021 - 23 Oct 2021)
- COVID-19 and Breast Cancer: Setback or Reset?, UMMC Pink October Webinar 2021: COVID-19 and Breast Cancer: Setback or Reset?, Breast cancer resource centre, UMMC (National) (06 Oct 2021 - 06 Oct 2021)
- Acute and late toxicities of systemic therapy, MSCT 2020, Clin Oncology Dept, UMMP (National) (11 Sep 2020 - 12 Sep 2020)
- Immunotherapy in metastatic breast cancer., Immuno-0ncology symposium in conjunction with World cancer research day, Department of Surgery, FOM, UM (National) (24 Sep 2019 - 24 Sep 2019)
- IORT in breast cancer, FARO Annual Meeting 2018, Indonesia radiation oncology society (International) (06 Sep 2018 - 08 Sep 2018)
- Antimetabolites, MSCT 2018, Clinical Oncology Dept, UMMC (National) (09 Mar 2018 - 10 Mar 2018)
- IORT in breast cancer, Live surgery IORT workshop, Dept of Surgery, UMMC (International) (24 Aug 2017 - 25 Aug 2017)
- Antimetabolites, Masterclass in Systemic Cancer Therapy, Dept of Clinical Oncology, UMMC (National) (04 Mar 2017 - 05 Mar 2017)
- RADIATION THERAPY IN NEUROBLASTOMA, MASPHO ASM 2016, MASPHO (National) (05 Nov 2016 - 06 Nov 2016)
- Epidemiology of cancer and current treatment modalities, 20th Malaysian Conference on Psychological Medicine, Malaysian Psychiatric Association (National) (03 Jun 2016 - 03 Jun 2016)
- Development of oncology training in middle income countries: the Malaysian model, AROICON 2015, AROI (International) (29 Nov 2015 - 29 Nov 2015)
- Hormonal therapy in breast cancer, 1st UMMC breast cancer public forum, Breast cancer resource centre,UMMC (Others) (18 Oct 2014 - 18 Oct 2014)
- An overview of cancer services in Malaysia; a virtual tour of Clin Onco Dept UMMC ; Oncology training in Malaysia, Department of Radiation Oncology, Technical University Munich Seminar, Department of Radiation Oncology, Technical University Munich (International) (04 Apr 2014 - 04 Apr 2014)
- Recurrent and metastatic NPC: issues and challenges, NPC research day, NPC Society Malaysia/Universiti Malaya (National) (04 Mar 2013 - 04 Mar 2013)
- Radiotherapy planning for breast cancer, Moving from 2D to 3D conformal radiotherapy workshop IAEA MAL 6020, MOH (National) (20 Jun 2012 - 22 Jun 2012)
- clinical research forum, 5th national conference on clinical research, ministry of health malaysia (National) (24 Jun 2011 - 24 Jun 2011)
- Radiation Therapy for cancer, Seminar perawatan Onkologi, PTj Pembangunan Insan (University) (28 Sep 2010 - 28 Sep 2010)
- Pengenalan Kanser Wanita dan Rawatan, Seminar kanser wanita dari perspektif biopsikososial, PTj Kebajikan Perubatan, PPUM (National) (11 Nov 2008)
- Oncology Endpoints: Their relevance in advanced cancer. , Palliative Care Symposium: Clinical Decision making and Ethics in Advanced Cancer, Faculty of Medicine, UM (National) (18 Apr 2007)
- An overview of radiation therapy in cancer treatment., A Continuous Professional Development Course in Radiotherapy, Radiology Dept., FOM, UM (National) (20 Dec 2005 - 22 Dec 2005)
- Radiotherapy of BAVM, Basic Neuro-interventional Course, Radiology Dept, FOM, UM (University) (11 Mar 2004 - 12 Mar 2004)
- Follow-up of treated breast cancer patients, MOS Annual Scientific Meeting, MOS (National) (20 Sep 2002 - 22 Sep 2002)
- Hormone therapy, Oncology in Palliative Care Seminar, Hospis Malaysia (National) (29 Jul 2001)
EVENT ORGANISER
- Not applicable, APCC 2011, MOS (International) (10 Nov 2011 - 11 Nov 2011)
- None, MOS Annual Scientific Meeting, MOS (National) (28 Sep 2002 - 30 Sep 2001)
ORAL PRESENTER
- Country Report and Report of 3rd RTC, Final review meeting IAEA RAS6086 project, IAEA (International) (13 Dec 2021 - 15 Dec 2021)
POSTER PRESENTER
- Outcome of malignant CNS tumours in young children from a single institution in Malaysia: 15-year experience with HEAD START 1 and 2 protocols, SIOP 2018, SIOP (International) (16 Nov 2018 - 18 Nov 2018)
- Prospective controlled study on the role of scalp hypothermia to prevent chemotherapy-induced alopecia in patients with breast cancer receiving anthracycline and taxane-based chemotherapy., APCC 2011, MOS (International) (10 Nov 2011 - 11 Nov 2011)
- Psycho-Oncology Referrals- A Single-Centre Review from Malaysia, IPOS 12th World Congress of Psycho-Oncology (International) (25 May 2010 - 29 May 2010)
- DEVELOPMENT OF SPECIALIST TRAINING PROGRAMME IN CLINICAL ONCOLOGY: THE MALAYSIA EXPERIENCE, ICARO 2009, IAEA (International) (27 Apr 2009 - 29 Apr 2009)
PRESENTER
- Country report, Progress Review Meeting of RAS6086, IAEA (International) (25 Nov 2020 - 26 Nov 2020)
- Covid 19 situation in Malaysia; impact on radiotherapy services, 1st FARO webinar, ISRO (International) (25 Sep 2020 - 25 Sep 2020)
- Clinical Oncology training in Malaysia, 1st FARO Council Member meeting, Japan as host country (International) (30 May 2015 - 30 May 2015)
- Key Performance Indices , Ministry of Health Workshop on Quality Assurance in Radiotherapy , MOH (National) (01 Aug 2006)
- Concurrent chemoradiotherapy for cervical cancer (CERVIX-III), FNCA workshop on Radiation Oncology, FNCA (International) (13 Dec 2004 - 17 Dec 2004)
OTHERS
- not applicable, ESMO Penang, MOS and ESMO (International) (22 Jan 2015 - 25 Jan 2015)
- Lung cancer, World conference on lung cancer, IASLC (International) (27 Oct 2013 - 30 Oct 2013)
- Breast cancer, Asia Pacific Breast Cancer Summit (International) (12 Apr 2013 - 13 Apr 2013)
- Jacob study for stomach cancer, JACOB study Investigator Meeting, Roche (International) (06 Mar 2013 - 08 Mar 2013)
- Oral presentations, ASCOMOS 2012, MOS (National) (08 Sep 2012 - 08 Sep 2012)
- Report on Lung cancer statistics, NCR Report Writing Workshop for year 2003-2005, MOH (National) (02 Mar 2007 - 04 Mar 2007)
- None, 37th Malaysia-Singapore Congress of Medicine, Academy of Medicine (National) (05 Sep 2003 - 07 Sep 2003)
ACADEMIC/PROFESSIONAL SERVICES
Evaluation
- (2021) Master of Clinical Oncology Fina Examination, University, (Internal Examiner)
- (2021) Master of Clinical Oncology Part 2 Examination, University, (Internal Examiner)
- (2021) part 1, 2 and Final Examinations Master of Clinical Oncology May 2021, (Internal Examiner)
- (2021) Tretament outcome for local recurrent nasopharyngeal carcinoma in UMMCfrom 2010-2017, (Internal Examiner)
- (2021) Development of real-time radioluminescent dosimetry system for medical application , (Panelist)
- (2021) Master of Clinical Oncology Part 1 Exam May 2021, University, (Internal Examiner)
- (2021) Master of Clinical Oncology Part2 Exam May 2021, University, (Internal Examiner)
- (2021) The Association of Physical Activity and Quality of Life Among Malaysian Breast Cancer Survivors, University, (Internal Evaluator)
- (2021) Treatment Outcome for Local Recurrent Nasopharyngeal Carcinoma in Ummc from 2010-2017, University, (Internal Examiner)
- (2021) Judge for Proffered/Research Paper At Faro 2021 Scientific Meeting, International, (External Evaluator)
- (2021) Judge for Profferred (Research) Papers At 5th Faro Scientific Meeting, International, (External Evaluator)
- (2021) Household Catastrophic Health Expenditure from Oral Potentially Malignant Disorders and Oral Cancer in Public Healthcare of Malaysia, International, (Reviewer)
- (2021) Household Catastrophic Health Expenditure from Oral Potentially Malignant Disorders and Oral Cancer in Public Healthcare of Malaysia, International, (Reviewer)
- (2021) Master of Clinical Oncology Part 1 Examination, University, (Internal Examiner)
- (2020) Mutation profile of breast cancer in Malaysian patients, (Reviewer)
- (2020) Role of vitamin D in preventing colororectal carcinogenesis: Systemayic review, (Reviewer)
- (2020) IMPACT OF PHYSICAL ACTIVITY ON PROGNOSIS AND QUALITY OF LIFE OF BREAST CANCER PATIENTS IN MyBCC STUDY , (evaluator)
- (2020) Examiner for part 1, part 2 and Final exam for Master of clinical Oncology, (Internal Examiner)
- (2020) MAGNITUDE AND FACTORS ASSOCIATED WITH THROMBOSIS AMONG CANCER PATIENTS RECEIVING CHEMOTHERAPY AT OCEAN ROAD CANCER INSTITUTE. , (Reviewer)
- (2020) Evaluate proposal defense by MSc candidate- Lee Yi Lin (17219644), (evaluator)
- (2020) Examiner for OSCE, (Internal Examiner)
- (2019) Logbook and continuous assessment, (Internal Examiner)
- (2019) Marking Part 2 COQ exam scripts. Examiner for Final Examination , (Internal Examiner)
- (2019) Jawatankuasa Pemeriksa bagi Peperiksaan ljazah Sarjana Sains Perubatan secara Penyelidikan /Kursus dan Penyelidikan (bagi komponen penyelidikan) i)Berkaitan dengan peperiksaan disertasi, menimbang laporan pemeriksa di atas disertasi seorang calon dan mengambil sesuatu keputusan termasuk mengenai tahap pencapaian disertasi itu ; ii) Dalam keadaan tertentu Jawatankuasa Pemeriksa boleh menjalankan peperiksaan viva dan / atau ujian lain difikirkan sesuai ; dan iii) Melaporkan kepada Senat mengenai apa-apa perkara yang berkaitan dengan mutu dan/atau perjalanan sesuatu peperiksaan., (Exam committee)
- (2019) All Trans Retinoic Acid (ATRA) Inhibits Telomerase Expression of BeWo Choriocarcinoma Cell (ATCC CCL-98) , (Reviewer)
- (2019) Exam script marker, (Internal Examiner)
- (2019) Treatment outcome of brain metastases in UMMC. , (Internal Examiner)
- (2018) Intracranial angiomatoid Fibrous histiocytoma with Hodgkin lymphoma , (Reviewer)
- (2018) The Great Masquerade: Empyema Thoracis as an Unusual Presentation of Primary Lung Malignancy , (Reviewer)
- (2017) Peperiksaan OSCE Stage 2 MBBS - RSA 1, (Internal Examiner)
- (2017) Relapsed Lymphoma Mimicking Venous Ulcer : A Case report for MJM, (Reviewer)
- (2017) Evaluation of research proposal under FRGS grant application, (Panel Penilai)
- (2017) Marking of exam scripts for Master of Clinical Oncology Part 1 May 2017 Exam, (Internal Examiner)
- (2017) Examiner for MD degree. Title of thesis: Management of psychological distress in cancer patients. MHB130001, (Internal Examiner)
- (2017) Lapatinib, trastuzumab and Capecitabine prolonged the survival of HER2-positive gastric cancer with leptomeningeal carcinomatosis: a case report., (Reviewer)
- (2017) "Stress levels during the journey of cancer treatment" , (Reviewer)
- (2017) Ref.: Ms. No. MJM-D-17-00148 Breast Ductal Carcinoma to Metaplastic Carcinoma- A Change in Cancer Morphology - A Case Report and Literature Review The Medical Journal of Malaysia , (Reviewer)
- (2017) Marking MCO Part 1 exam scripts , (Internal Examiner)
- (2017) Outcome of patients with cord compression treated in UMMC. Master of Clinical Oncology Final Exam, (Internal Examiner)
- (2017) Review and select abstracts for FARO 2017 scientific meeting, (Reviewer)
- (2017) Comparison of the seventh and eight editions of the UICC/AJCC staging system for NPC; analysis of 1317 patients treated with IMRT at two centres , (Reviewer)
- (2017) Chemotherapy for metastatic colon cancer -No effect on survival when the dose is reduced due to side-effects. BMC cancer , (Reviewer)
- (2016) Evaluate suitability of research proposal/project for consideration of sciencefund (MOSTI) research grant, (Evaluating panel)
- (2016) Treatment Of heavily pre-treated metastatic breast cancer with Eribulin: First local experience in Sabah. , (Reviewer)
- (2016) Master of Clinical Oncology Part 1, 2 and Final Exams , (Internal Examiner)
- (2016) Triple negative breast cancer survival and prognostic factors., (Internal Examiner)
- (2016) Evaluate the suitability of the following article for publication in BMC Cancer journal: Chemotherapy on metastatic colon cancer:No effect on survival when dose is reduced due to side-effects., (Reviewer)
- (2016) Chemotherapy Induced Neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: A Cohort Study, (Reviewer)
- (2016) Management of psychological distress in cancer patients: Focus on brief mindful therapy, (Assessor)
- (2016) Medical Journal Malaysia: Gastric ulcer than turned out to be metastasis of a synovial sarcoma: A case report and literature review., (Reviewer)
- (2016) Pretreatment Expression of Blood and Tissue Biomarkers as a Predictor of Tumor Response After Neoadjuvant Chemoradiation in Rectal Cancer, (Reviewer)
- (2016) Review research abstracts submitted for FARO 2016. Provide scoring for each as per guideline from organising commitee., (Assessor)
- (2015) Symptoms burden and QoL. Comparison between CAM and non-CAM users during breast cancer chemotherapy in 2 public hospitals in Malaysia., (Internal Examiner)
- (2015) Palliative to curative treatment: A case of stage 4 mucinous adenocarcinoma successfully treated with metronomic capecitabine in combination with bevacizumab and surgery., (Reviewer)
- (2015) marking exam scripts and viva voce , (Internal Examiner)
- (2014) Editorial board member for International Journal of Recent Research in Life Sciences (IJRRLS), (Editor)
- (2013) JUMMEC Case study: Squinting eyes: A presenting complaint in a young adult with glioblastome multiforme. , (Reviewer)
- (2013) MEASUREMENT OF BLADDER VOLUME VARIATIONS USING PORTABLE ULTRASOUND EQUIPMENT: INTRODUCTION OF DRINKING PROTOCOL , (Reviewer)
- (2013) Master of Clinical Oncology Part 1,2 and Final Exam , (Internal Examiner)
- (2013) Appointed as external assessor from UCSI University to assess suitability of an academic staff from UCSI for promotion from assoc. prof. to full prof. , (External Assessor)
- (2013) Metastatic melanoma to the stomach; a case report , (Reviewer)
- (2013) The treatment outcome of radical radiotherapy in laryngeal cancer. , (Reviewer)
- (2013) Survival of primary lung cancer patients treated in Brunei darussalam , (External Examiner)
- (2013) MJM Chemotherapy extravasation at Hospital Pulau Pinang Malaysia , (Reviewer)
- (2012) Association of creatinine clearance with neutropenia in breast cancer patients undergoing chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide (FAC), (Reviewer)
- (2009) Induction chemotherapy with paclitaxel, ifosfamide and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer., (Reviewer)
- (2008) Medulloblastoma: Cranial spinal junctional techniques., (Reviewer)
- (2008) Poster presentations
- (2008) Advanced Diploma in Nursing Oncology (UM)
- (2008) Bachelor in Medical Sciences (Diagnostic Imaging)(UKM) Bachelor in Medical Sciences (Radiotherapy)(UKM) PhD(Diagnostic Imaging)(UKM) PhD(Radiotherapy)(UKM)
- (2006) Master of Clinical Oncology Part 1 Exam, (Internal Examiner)
Contribution to external organisation
- (2022) Chair of Faro Education and Training Committee, International, (Resource Person)
- (2021) Neratinib Expert Meeting, National, (Expert Advisor)
- (2021) Malaysia Neratinib Expert Meeting, National, (Expert Advisor)
- (2021) Msd Expert Input Forum On Pembrolizumab in Tnbc (Studies Keynote 355 and 522), National, (Expert Advisor)
- (2021) Msd Breast Cancer Advisory Board Meeting, National, (Expert Advisor)
- (2021) National Project Coordinator for Iaea Project Ras6086, International, (Technical Advisor)
- (2019) National Project Coordinator forRCA/IAEA RAS6086 project, IAEA
- (2018) RCA-IAEA project RAS6086 - Strengthening cancer management programmes in RCA states parties through collaboration with national and regional radiation oncology societies., IAEA
- (2018) Evaluate the suitability of eribulin in patients who have failed one line of chemo in the advanced metastatic setting., Drug Control Authority, MOH Malaysia
- (2017) Evaluate the suitability of TS-1 tablet in terms of bioequivalence as compared to TS-1 capsule to be used for the same clinical indications., DCA, MOH
- (2016) Evaluate suitability of research project/proposal for consideration of sciencefund(MOSTO) research grant, Universiti Malaya
- (2016) Evaluate the suitability of tegafur in the treatment of NSCLC for the purpose of additional indication approval., Drug Control Authority Ministry of Health Malaysia
- (2016) Evaluate the suitability of tegafur in the treatment of pancreatic cancer for the purpose of additional indication approval., Drug Control Authority Ministry of Health Malaysia
- (2016) Evaluate the suitability of afinitor in the treatment of advanced renal cell carcinoma in patients with disease progression following treatment with anti VEGF, Drug Control Authority, Ministry of Health, Malaysia
- (2016) Evaluate the suitability of tegafur in the treatment of colorectal cancer for the purpose of additional indication approval., Drug Control Authority Ministry of Health Malaysia
- (2016) Evaluate the suitability of cyramza in the treatment of stomach/GOJ tumours, colorectal and NSCLC for the purpose of registration., National Pharmaceutical Control Bureau, MOH Malaysia
- (2015) Evaluate suitability of nindetanib esilate in advanced NSCLC for the purpose of new drug registration., Pihak Berkuasa Kawalan Dadah Biro Pengawalan Farmaseutikal Kebangsaan Kementerian Kesihatan Malaysia
- (2015) Evaluate suitability of vismodegib in advanced basal cell carcinoma for the purpose of new drug registration., Pihak Berkuasa Kawalan Dadah Biro Pengawalan Farmaseutikal Kebangsaan Kementerian Kesihatan Malaysia
- (2013) Root cause analysis, UMMC
- (2012) Penilaian ubat-ubatan kimoterapi, Pusat perubatab Universiti Malaya
- (2012) Radiation oncology curriculum in developing countries, IAEA
- (2009) Clinical Oncology Specialty Committee, Universiti Malaya
- (2008) Organising Committee for APCC 2011, Malaysian Oncological Society
- (2005) International Atomic Energy Agency (IAEA) Project Coordinator for project RCA RAS 6040 Improvement in Quality of Radiotherapy for Frequent Cancers in the Region., IAEA
- (2005) To give input with regards to the conduct and management of clinical trials and in particular industry sponsored trials managed by Clinical Investigation Centre, UM, Clinical Investigation Centre, Faculty of Medicine , UM
- (2003) Structuring, data collection, analysis and report writing, National Cancer Registry
- (2001) Medical Advisory Committee member. Advise on clinical issues at UMMC., UMMC
Contribution to event
- (2021) Report of Faro Etc 2021 Activities, International, (Participant)
- (2021) Report of Faro Etc Activities 2021, International, (Participant)
- (2021) Nccom E-Portfolio, National, (Panelist/Moderator)
- (2021) Chairperson of Scientific Session, International, (Panelist/Moderator)
- (2021) Scientific Committee, National, (Event Organiser)
- (2021) Scientific Committee, National, (Event Organiser)
SUPERVISION
Under Graduate Students
- (2012) Describing the clinical management and resource use of solid tumour patients with chemotherapy-related febrile neutropenia in UMMC
Postgraduate Student
Master
-
(2020) PROSPECTIVE EVALUATION OF RADIATION-INDUCED LATE TOXICITIES IN HEAD AND NECK CANCERS IN UNIVERSITY MALAYA MEDICAL CENTRE, Nurhidayu Salimin
-
(2020) -, JASMIN MUNCHAR BINTI ELIAS
-
(2020) -, SITI MARIAM BINTI YACOB
-
(2020) -, SHAZWANI SHABUDIN
-
(2020) -, AMIR ARIF AHMANUL
-
(2020) -, NUR NADYA BINTI MOHAMAD NASIP
-
(2020) -, CHIA WEI JONATHAN CHEW
-
(2020) -, MOHD FAIRUZ JAYAH
-
(2020) -, MUN CHEE CHONG
-
(2020) -, ADELINE MICHELLE MATHEW
-
(2020) -, JIAN WEN LEE
-
(2020) -, WEI QUAN WONG
-
(2020) -, FION TEO
-
(2020) -, ILEENA ABDUL MUIN
-
(2020) -, OOI PO LIN
-
(2020) -, NUR HIDAYAH HABIL
-
(2020) Comparison of dosimetric coverage of RTOG and ESTRO-defined target volumes for chest wall and supraclavicular fossa radiotherapy with standard field-based radiotherapy in University Malaya Medical Centre., Chiam Poh Jeann
-
(2020) clinical supervision, Tan Li Mei
-
(2020) clinical supervision, Tang Shir Ley
-
(2020) clinical supervision, Nor Faizah Abd Muin
-
(2020) clinical supervision, Liew Zhi Hao
-
(2020) clinical supervision, Jasmin Munchar
-
(2020) clinical supervision, Fatimahtulzahrah saparmin
-
(2020) clinical supervision, Daniel Gan
-
(2020) clinical supervision, Chen May Feng
-
(2020) clinical supervision, Anbarasan Anbazagan
-
(2019) clinical supervision, Shazlin Hasbullah
-
(2019) Clinical supervision, Tun Mohd Azlan Mohd Nor
-
(2019) Clinical supervision, Sum Ying Ying
-
(2019) Clinical supervision, Shazlin Md Hasbullah
-
(2019) clinical supervision, Rufus Jesudas
-
(2019) clinical supervision, Nadiah Zainal
-
(2019) clinical supervision, Nurul Iman Fathi
-
(2019) Clinical supervision, Mohd Fahim Abd Rahman
-
(2019) clinical supervision, Magdalene Anuth Ranjit
-
(2019) clinical supervision, Nor Hayati Hashim
-
(2019) Clinical supervision, Jason Lai Shen Chang
-
(2019) clinical supervision, Chan Ming Jun
-
(2019) Cancer Trend, Utilisation of Resources and Workload Analysis at a Tertiary Academic Hospital in a Developing Country, Daniel Gan Eng Hwee
-
(2018) Clinical supervision, Tang Seng Paul
-
(2018) -, CHIAM POH JEANN
-
(2018) -, ANNANDAKUMAR BALAKRISHNAN
-
(2018) -, AHMAD NAUFAL BIN MD ALWI
-
(2018) -, CHEN MAY FENG
-
(2018) -, DANIEL GAN ENG HWEE
-
(2018) Clinical supervision, Noor Nabila Mohamed
-
(2018) -, NOOR NABILA BINTI MOHAMAD
-
(2018) -, VICKEE RAJESWARAN
-
(2018) Clinical supervision, Nisha Mohd Shariff
-
(2018) -, IZZATI BINTI WAN MAHARUDDIN
-
(2018) Clinical supervision, Chiam Poh Jeann
-
(2018) -, SUM YING YING
-
(2018) -, MOHD FAHIM BIN ABD RAHMAN
-
(2018) Clinical supervision, Ahmad Naufal Md Alwi
-
(2018) -, CHONG CHAN TENG
-
(2018) -, IZZATI BINTI ROSLI
-
(2017) -, RIZMA BINTI MOHD ZAID
-
(2017) -, ENG JIE YI
-
(2017) -, GOH HUEY LUEN
-
(2017) -, AUDI ADAWIAH BINTI SULAIMAN SHAH
-
(2017) -, YUSRA HADI
-
(2017) -, NUR FA'IZAH BINTI AB MUIN
-
(2017) -, ARDIF BIN DAMIRI
-
(2017) -, KHAMINI A/P THARUMARAJAH
-
(2017) -, MOHD ASYRAF BIN MD NOR @ MOHD ZAIN
-
(2017) -, ALDRIN JASPER PLACIDUS
-
(2017) -, NORHIDAYU BT SALIMIN
-
(2017) -, TANG SHIR LEY
-
(2017) -, TANG SEEN PAUL
-
(2017) -, NURUL IMAN BINTI FATHI
-
(2017) -, SANDYA SUBRAMANIAM
-
(2017) -, RANGASAMY A/L RAMACHANDRAN
-
(2017) -, PUWANESWARRY A/P MIUNDY
-
(2017) -, TUN MOHD AZLAN BIN MOHAMED NOR
-
(2017) Chemoport usage and complication rates in UMMC., Heng Fook Yew
-
(2017) Acute radiation related oral toxicities in HNSCC patients in UMMC: A prospective study, Kumutha
-
(2017) Timing And Outcome Of Palliative Chemotherapy, Teh Hooi Lay
-
(2017) clinical supervision, Patricia Shamani
-
(2017) Palliative radiotherapy for advanced cancer: Are we giving it to the right patient at the right time?, Syadwa
-
(2017) clinical supervision, Puvaneswarry
-
(2017) clinical supervision, Teh Hooi Lay
-
(2017) clinical supervision, Aldrin Jasper
-
(2017) clinical supervision, Tan Li Mei
-
(2017) clinical supervision, Mohd Asyraf
-
(2017) clinical supervision, Kumutha
-
(2017) clinical supervision, Eng Jie Yi
-
(2017) clinical supervision, Syadwa
-
(2017) clinical supervision, Rosdiana
-
(2016) clinical supervision, Lee Hong Moi
-
(2016) clinical supervision, Lee Dai Wee
-
(2016) clinical supervision, Sangeeta
-
(2016) -, SANGEETA VAHNALINGAM
-
(2016) clinical supervision, lavannia
-
(2016) -, NAJIHAH BINTI ABU BAKAR
-
(2016) clinical supervision, hadi
-
(2016) -, NGU MING RUEY
-
(2016) clinical supervision, Fiona
-
(2016) -, NIK ROZLIN ELINI BINTI MOHD SHUHAIMI
-
(2016) clinical supervision, chan ming jun
-
(2016) -, SYAFIRIN BIN AB SANI
-
(2016) -, LEE DAI WEE
-
(2016) -, NARENDRAN A.L KORISATAN
-
(2016) -, SOMA BAVANI SIVARAJ
-
(2016) clinical supervision, syafirin
-
(2016) -, CHAN MING JUN
-
(2016) -, VANCE KOI YUNG CHEAN
-
(2016) clinical supervision, Vance Koi
-
(2016) -, ANGEL KWAN KHOR NEE
-
(2016) -, TEH HOOI LAY
-
(2016) -, NUR JIHAN BT IRWAN TAN
-
(2016) clinical supervision, Tan Li Mei
-
(2016) -, EZNAL IZWADI MOHD MAHIDIN
-
(2016) -, LEE HONG MOI
-
(2016) -, PATRICIA SHAMANI A/P SOOSAINATHAN
-
(2016) -, LAVANNIA A/P RAJARATENAM
-
(2016) -, SRI KISHA A/P SUBRAMANIAM
-
(2015) clinical supervision, Hadi Jalil
-
(2015) clinical supervision, Kumutha a/p Chalaya
-
(2015) -, FELIX LIAU YEE FAN
-
(2015) clinical supervision, Nik Rozlin Elini Mohd Shuhaimi
-
(2015) -, KUMUTHA A/P CHALAYA
-
(2015) clinical supervision, Heng Fook Yew
-
(2015) clinical supervision, Lee Hong Moi
-
(2015) clinical supervision, Ngu Ming Ruey
-
(2015) clinical supervision, Alagu Manthiram Ramasamy
-
(2015) -, NISHA BINTI MOHD SHARIFF
-
(2015) -, ROSDIANA BINTI ABD RAHIM
-
(2015) clinical supervision, Felix Liau Yee Fan
-
(2015) Chemoport usage and its complications in the oncology dept, UMMC, Heng Fook Yew
-
(2015) -, SYAZNI BINTI BADROL HISHAM
-
(2015) clinical supervision, Nur Jihan Irwan Tan
-
(2015) clinical supervision, Ravivarma Prathapan
-
(2015) clinical supervision, Rosdiana Abd Rahim
-
(2015) clinical supervision, Syazni Badrol Hisham
-
(2015) -, RAVIVARMA PRATHAPAN
-
(2015) -, HADI BIN AB. JALIL
-
(2015) -, HENG FOOK YEW
-
(2015) -, ALAGU MANTHIRAM A/L RAMASAMY
-
(2015) clinical supervision, Nisha Mohd Shariff
-
(2014) Clinical supervision, Gan Ben Jin
-
(2014) -, LIM YI WAY
-
(2014) -, GAN BENG JIN @ BENJAMIN GAN
-
(2014) Clinical supervision, Narendran K
-
(2014) Timing and outcome of palliative radiotherapy., Syadwa
-
(2014) Clinical supervision, Lim Yaeh Ni
-
(2014) -, SYADWA BINTI ABDUL SHUKOR
-
(2014) Clinical supervision, Shadwa
-
(2014) -, LIM YUEH NI
-
(2014) Clinical supervision, Lim Yi Way
-
(2013) -, CHOONG SWEE HSIA
-
(2013) -, FIONA SULING LIAN
-
(2013) -, NOOR ZAFIFAH BINTI ZAKARIA
-
(2013) -, KHAIRIYAH BINTI SIDEK
-
(2013) -, TEO YIN KEONG
-
(2013) -, SOW WEN JEN
-
(2013) Clinical supervision, Tan Li Mei
-
(2013) -, TAN LI MEI
-
(2013) Clinical supervision, Choong Swee Hsia
-
(2013) Clinical supervision, Khairiyah Sidek
-
(2013) Clinical supervision, Noor Zafifah Zakaria
-
(2013) Clinical supervision, Sow We Jen
-
(2013) Clinical supervision, Fiona Suling Lian
-
(2013) Clinical supervision, Teo Yin Keong
-
(2012) Clinical supervision, Sucharit Pongprakyun
-
(2012) Clinical supervision, Prathepamalar Yehgambaram
-
(2012) Clinical supervision, Eznal Izwadi Mohd Mahidin
-
(2012) Clinical supervision, Ang Tick Suan
-
(2012) adjuvant trastuzumab in early breast cancer: a`retrospective cohort study in two oncology centres in malaysia, Harissa Husainy Hasbullah
-
(2011) -, INA SHALINY A/P DURAISAMY
-
(2011) Clinical supervision, Han Albert Dicken
-
(2011) Clinical supervision, Junie Khoo Yu Yen
-
(2011) Clinical supervision, Ng Boon Huat
-
(2011) Clinical supervision, Marfuah Nik Eezamuddeen
-
(2011) -, MARFU'AH BINTI NIK EEZAMUDDEEN
-
(2011) Clinical supervision, Ina Shaliny Duraisamy
-
(2011) Clinical Supervision, Santhi Nadarajan
-
(2011) Clinical supervision, Nahjatul Kursyiah Abd Ghafar
-
(2011) Clinical supervision, Soma Bavani Sivaraj
-
(2011) Clinical supervision, Tang Weng Heng
-
(2011) Clinical supervision, Winnie Ng Nyek Ping
-
(2011) -, HAN ALBERT DICKEN
-
(2011) -, JUNIE KHOO YU-YEN
-
(2010) -, ASTRID SINARTI BINTI HASSAN
-
(2010) Clinical supervision, Arnil George Sirimanne
-
(2010) Clinical supervision, Astrid Sinarti Hassan
-
(2010) Clinical supervision, Leong Siew Mooi
-
(2010) Clinical supervision, Malwinder Singh Sandhu
-
(2010) Clinical supervision, Sunitha Kumaran
-
(2010) -, SUNITHA A/P KUMARAN
-
(2010) Clinical supervision, Tan Chih Kiang
-
(2010) Radiation-induced hypothyroidism following radical radiotherapy for head and neck cancer, Lim Chun Sen
-
(2010) The Establishment of In-vitro Standard Dose Calibration Curve with High Energy X-ray and Measurement of The Equivalent Dose In Cancer Patients Treated with Radiotherapy Using Biological Dosimetry Technique, Halim Abdul Rahman
-
(2010) -, MALWINDER SINGH SANDHU
-
(2010) PROTEOMICS STUDIES OF SERA OF PATIENTS WITH NASOPHARYNGEAL CARCINOMA: A LECTIN-BASED APPROACH, RAMARAO A/L SERIRAMALU
-
(2010) Clinical supervision, Wong Yoke Fui
-
(2009) Clinical supervision, Noor Syuhadah A. Karim
-
(2009) Symptoms prevalence, characteristics and coping strategies among adult oncology patients., Nor Aziyan Yahya
-
(2009) Clinical supervision, Atiliana Mohamed Adib
-
(2009) Clinical supervision, Harissa Husainy Hasbullah
-
(2009) Clinical supervision, Muthukumaran
-
(2009) Clinical supervision, Vaishnavi Jeyasingam
-
(2008) Clinical supervision, Suhana Yusak
-
(2008) Clinical supervision, Siti Zaleha Md Sani
-
(2008) Concurrent chemoradiotherapy in H&N cancer, Mastura Md Yusuf
-
(2008) Clinical supervision, Fong Chin Heng
-
(2008) Clinical supervision, Cheah Soon Keat
-
(2008) Clinical supervision, Noorzulali Haron
-
(2008) Clinical supervision, Natasha Mohd Hashim
-
(2007) Proteomic studies in patients with NPC: lectin-based approach, Ramarao a/l Seriramalu
-
(2007) Clinical supervision, Lee Wei Ching
-
(2007) Clinical supervision, Ibtisam Muhammad Nur
-
(2007) Clinical supervision, Hafizah Zaharah Ahmad
-
(2007) Clinical supervision, Flora Chong Li Tze
-
(2007) Analysis of breast cancer in elderly women:cohort of 1994-2004 treated in UMMC, Vincent Phua Chee Ee (University of Malaya (UM))
-
(2006) Concurrent chemoradiation for patients with nasopharyngeal carcinoma treated in UMMC between 2001 and 2003., Nik Muhd Aslan Abdullah (University of Malaya (UM))
-
(2006) Clinical supervision, Yu Kong Leong
-
(2006) Clinical supervision, Ros Suzanna Ahmad Bustamam
-
(2006) Clinical supervision, Lau Kah Liew
-
(2006) Clinical supervision, Hayani Abdul Wahid
-
(2005) Cinical supervision, Kua Voon Fong
-
(2005) Clinical supervision, Chandra Kumar A/l Krishnan
-
(2005) Clinical supervision, Chan Wee Han
-
(2005) Clinical supevision, Ng Poh Huat
-
(2005) In vivo skin dose assessment for breast cancer dring radiotherapy treatment using gafchromic film (EBT) detector, Mahzom Pawanchek (University of Malaya (UM))
-
(2004) The evolution of 2-D to 3-D radiation therapy practice in the treatment of nasopharyngeal carcinoma., Sin Sze Yarn (A0800108)
-
(2004) Clinical supervision, Yang Rashidi Abdullah
-
(2004) Clinical supervision, Wan Zamaniah Wan Ishak
-
(2004) Clinical supervision, Rozita Abdul Malik
-
(2004) Clinical supervision, Fabian Lee Wei Yuen
-
(2003) Clinical supervision, Tan Boon Seang
-
(2003) Clinical supervision, Adlan Suhaimi Ahmad
-
(2003) Assessment of patients with carcinoma of the cervix treated with definitive radiotherapy at UMMC., Si Lay Khaing (University of Malaya (UM))
-
(2002) Clinical supervision, Farah Zaffar Hayat
-
(2002) Clinical supervision, Azura Deniel
TEACHING
Master
- (2021) Master of Clinical Oncology Part 2 Clinical Teaching
- (2020) MAGT6300 - Magt6300
- (2020) MAGT -
- (2019) MAGT -
- (2019) MAGT6300 - Magt6300
- (2018) MAGT -
- (2018) MAGT - Master of Clinical Oncology
- (2016) MAGT - Master of Clinical Oncology
- (2015) MAGT - Master of Clinical Oncology
- (2015) Master of Clinical Oncology
- (2014) MAGT - Master of Clinical Oncology
- (2013) MAGT - Master of Clinical Oncology
- (2012) MAGT - Master of Clinical Oncology
- (2011) MAGT - Master of Clinical Oncology
- (2011) Master of Medical Physics
- (2010) MAGT - Master of Clinical Oncology
- (2009) MAGT - Master of Clinical Oncology
- (2008) MAGT - Master of Clinical Oncology
- (2007) MAGT - Master of Clinical Oncology
- (2006) MAGT - Master of Clinical Oncology
- (2006) Master of Medical Physics
- (2005) MAGT - Master of Clinical Oncology
- (2005) Master of Otorhinolaryngology
- (2005) Master of Medical Physics
- (2004) Master of Obstetrics & Gynaecology
- (2004) Master of Medical Physics
- (2004) Master of Internal Medicine
- (2004) MAGT - Master of Clinical Oncology
- (2003) NA - Master of Medical Physics
- (2003) Master of Clinical Oncology
- (2002) Master of Medical Physics
- (2002) Master of Clinical Oncology
- (2001) Master of Medical Physics
- (2000) Master of Medical Physics
Bachelor/First Degree
- (2021) UMMP - Universiti Malaya Medical Programme
- (2021) UMMP -
- (2021) UMMP -
- (2020) MID2005 - Basic Medical Science Iii
- (2020) UMMP -
- (2018) UMMP - Ummp
- (2018) UMMP -
- (2015) ONCOLOGY - Ummp
- (2015) Ummp
- (2007) Mbbs
- (2007) Basic Degree in Nursing Sciences
- (2006) Basic Degree in Nursing Sciences
- (2004) Mbbs
- (2004) Basic Degree in Nursing Sciences
- (2003) Basic Degree in Nursing Sciences
- (2002) Mbbs
- (2002) Basec Degree in Nursing Sciences
- (2001) Mbbs
- (2001) Basic Degree in Nursing Sciences
- (2000) Basic Degree in Nursing Sciences
- (2000) Mbbs
Others
- (2008) ADNS - Advanced Diploma in Nursing (Oncology)
- (2006) ADNS - Advanced Diploma in Nursing (Oncology)
- (2004) ADNS - Advanced Diploma in Nursing (Oncology)
- (2003) Advanced Diploma in Nursing (Oncology)
- (2004) Diploma in Radiography
- (2003) Diploma in Radiography
- (2002) Diploma in Radiography
- (2001) Diploma in Radiography
- (2000) Diploma in Radiography
PATENT/IPR
- Master of Clinical Oncology Programme Syllabusliterary work (University)
SOCIAL RESPONSIBILITY ACTIVITIES
- Organiser of Iaea Ras6086 Regional Training Course On Multimodality Treatment in Palliative Radiotherapy, (22 Mar 2021 - 25 Feb 2021)
- Searog Council Advisor, (01 Jan 2019 - 31 Dec 2019)
- Faro Council Member Representing Malaysian Oncological Society and Malaysia, (01 Jan 2019 - 31 Dec 2019)
- Breast Cancer Public Forum, (18 Oct 2014 - 18 Oct 2014)
- Smk Seksyen 9 Shah Alam Niners a+ Committee Member, (01 Jul 2013 - 12 Oct 2013)
- Women's Integration Society, (01 Jan 2002)